Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001878078 | SCV002157904 | uncertain significance | Mitochondrial hypertrophic cardiomyopathy with lactic acidosis due to MTO1 deficiency | 2022-05-27 | criteria provided, single submitter | clinical testing | This sequence change disrupts the translational stop signal of the MTO1 mRNA. It is expected to extend the length of the MTO1 protein by 12 additional amino acid residues. This variant is present in population databases (rs770798772, gnomAD 0.004%). This variant has not been reported in the literature in individuals affected with MTO1-related conditions. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |